NanoVibronix Issues Letter to Shareholders
NanoVibronix, Inc., a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave Portable Ultrasonic Therapeutic Devices, today issued a... | May 18, 2023
Stay updated with breaking news from Painshield Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NanoVibronix, Inc., a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave Portable Ultrasonic Therapeutic Devices, today issued a... | May 18, 2023
Management's Discussion and Analysis of Financial Condition and Results of Operations is intended to provide a reader of our financial statements with a narrative from the perspective of our... | April 17, 2023
28.11.2022 - NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its ... Seite 1
NanoVibronix Adds Additional Product to Federal Supply Schedule - read this article along with other careers information, tips and advice on BioSpace
NanoVibronix Amends and Expands Distribution Agreement for Its PainShield® and PainShield Plus® ELMSFORD, N.Y.--(Business Wire)-- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has expanded and replaced its original distribution agreement with Ultra Pain Products, Inc. (“UPPI”). Under the terms of the new agreement, which extend the term and increase minimum purchase requirements, UPPI will be the exclusive distributor...